SIK2 activates the autophagy‒apoptosis pathway through SP1 regulation to inhibit the progression of hepatocellular carcinoma
Sheng Fan(First Affiliated Hospital of Xiamen University), Yueyin Pan(University of Science and Technology of China)
Cited by 0
Related Papers
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
|European Journal of Cancer|2022|57